![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
Preview |
PDF
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
1MB |
| Item Type: | Review |
|---|---|
| Title: | The role of Neurofilament light (NfL) and glial fibrillary acidic protein (GFAP) in MS and AQP4-NMOSD: advancing clinical applications |
| Creators Name: | Samadzadeh, S. and Sleator, R.D. |
| Abstract: | Fluid biomarkers such as Glial Fibrillary Acidic Protein (GFAP) and Neurofilament Light (NfL) play important roles in the diagnosis, monitoring, and evaluation of therapeutic responses in conditions such as Multiple Sclerosis (MS) and Aquaporin-4 Neuromyelitis Optica Spectrum Disorder (AQP4-NMOSD). These biomarkers offer key insights into the underlying pathophysiological mechanisms of these diseases, enabling effective follow-up and personalized treatment approaches, which are essential for improving patient outcomes. Herein, we synthesize the structural attributes, functional roles, and clinical significance of GFAP and NfL in the context of MS and AQP4-NMOSD. We explore the critical implications of these biomarkers in disease manifestation and progression, emphasizing the necessity to develop standardized methodologies and multicentric studies to confirm their clinical applicability. |
| Keywords: | Biomarkers, Glial Fibrillary Acidic Protein, Neurofilament Light, Multiple Sclerosis, Aquaporin-4 Neuromyelitis Optica Spectrum Disorder |
| Source: | eNeurologicalSci |
| ISSN: | 2405-6502 |
| Publisher: | Elsevier |
| Volume: | 38 |
| Page Range: | 100550 |
| Number of Pages: | 1 |
| Date: | March 2025 |
| Official Publication: | https://doi.org/10.1016/j.ensci.2025.100550 |
Repository Staff Only: item control page
